Tenet Healthcare

Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment consists of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tenet Healthcare reports robust Q4 earnings, eyes growth opportunities

Tenet Healthcare's Q4 2022 performance showcased strong financial results, effective cash flow management, and positive growth projections for 2023.
While facing challenges such as cyber attacks and COVID-related disruptions, the company is focused on addressing contract labor costs and driving growth.
Opportunities for Tenet Healthcare include organic growth, strategic acquisitions, and enhancing operational efficiencies to drive future success.
Overall, Tenet Healthcare's performance, strengths, challenges, and opportunities position the company for continued growth and financial stability.

Tenet Healthcare excels in Q1 2023, eyes growth opportunities

Tenet Healthcare's Q1 2023 performance was robust, driven by strong results in USPI and the hospital segment.
Challenges include deferred procedures in certain healthcare services and managing labor shortages, but opportunities exist in ortho procedure growth and improved contract labor rates.
The company's focus on efficiency and partnership benefits bode well for future growth and margin improvement.

Tenet Healthcare reports robust Q2 earnings, raises full-year guidance

Tenet Healthcare's Q2 2023 performance reflects strong financial results across segments, with raised EBITDA guidance and solid cash flow generation.
While facing challenges in specific markets and increased CapEx, the company remains focused on sustaining profitability and enhancing shareholder value.
Opportunities lie in continued growth prospects, strategic investments, and operational improvements to drive long-term success and market expansion.
Overall, Tenet Healthcare's performance highlights resilience, strategic focus, and commitment to delivering value to shareholders amidst evolving market dynamics.

Tenet Healthcare excels in Q3, eyes growth in USPI specialties

Tenet Healthcare's Q3 2023 performance showcased strong financial results across its segments, with a focus on high acuity services and cost control.
While facing challenges such as rising medical fee costs and clinical denials, Tenet is strategically positioned to capitalize on growth opportunities in USPI specialties and margin expansion.
The company's emphasis on technology investments, labor optimization, and strategic decision-making underscores its commitment to sustainable growth and operational efficiency.
With an upwardly revised guidance for 2023 and plans for 2024 formulation, Tenet Healthcare is poised for continued success through prudent financial management and strategic initiatives.

Tenet Healthcare posts robust Q4 earnings, eyes growth opportunities

Tenet Healthcare delivered strong financial results in Q4 2023, with solid EBITDA figures across its segments and a positive outlook for 2024. While facing challenges such as regulatory impacts and labor management, the company remains focused on capital allocation priorities and growth opportunities in high acuity services and ASC diversification.

Tenet Healthcare excels in Q1 2024, eyes growth opportunities

Tenet Healthcare's Q1 2024 performance showcased strong financial results, with notable growth in adjusted EBITDA across segments and successful deleveraging.
The company's strategic initiatives, including divestitures, acquisitions, and focus on revenue optimization, position it well for future growth and profitability.
Despite challenges like margin dilution from recent acquisitions and calendar effects, Tenet's focus on enhancing operational efficiency and seizing growth opportunities remains key.

Tenet Healthcare excels in Q2, eyes growth through efficiency

Tenet Healthcare's Q2 2024 earnings call reflects strong financial performance, strategic initiatives, and a positive outlook for the full year, underpinned by revenue growth and operational enhancements.
While facing challenges in margin management and revenue mix sustainability, Tenet's focus on efficiency, debt reduction, and shareholder value creation positions it well for future growth.
The company's emphasis on operational efficiency, capacity utilization, and strategic investments underscores its commitment to delivering quality care, driving performance, and seizing growth opportunities.

Tenet Healthcare excels in Q3, eyes strategic growth opportunities

Tenet Healthcare's Q3 2024 performance reflects robust revenue growth, margin expansion, and increased guidance, underpinned by strong cash generation and strategic financial management.
While facing challenges in forecasting and capital allocation, Tenet's focus on operational efficiency and shareholder value creation positions it well for future growth and resilience.
By capitalizing on opportunities for strategic investments, debt optimization, and prudent capital deployment, Tenet can navigate industry complexities and drive sustainable value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.

Riding high on its strategic measures and cost-cutting methods, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.

Here's Why You Should Retain Tenet Healthcare (THC) Stock

Acadia Healthcare

HCA Healthcare

Universal Health Services

While the Zacks Medical-Hospital industry was at the receiving end of the coronavirus pandemic, which caused a decline in elective procedures and consequently, dried up the revenues, federal dollars came to the industry’s rescue to minimize its damages to a certain extent..

4 Hospital Stocks to Gain from Improving Admissions, Federal Aid

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) plans to report results for its third quarter ended September 30, 2020 after the market closes on Tuesday, October 20, 2020. The company will host a conference call the following morning, Wednesday, October 21, at 10:00 a.m. Eastern time (9:00 a.m. Central time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors. The audio archiv

Tenet to Report its Third Quarter Results on October 20

Universal Health (UHS) and Tenet Healthcare (THC) are poised to grow. On comparative evaluation, we try to discover which is a more profitable bet based on the fundamentals.

UHS or THC: Which is a Better-Positioned Stock Right Now?

A nearly 30% price target cut from a noted investment bank was the culprit.

Why Tenet Healthcare Dived 13% on Monday

Centene

Community Health Systems

Molina Healthcare

The death of justice Ruth Bader Ginsburg changes the dynamics of the upcoming Obamacare case at the high court.

Health-care stocks fall on uncertainty over Supreme Court and Obamacare

Tenet Healthcare: A Great Play In The Healthcare Space

Tenet Healthcare shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.
The post Stocks Showing Rising Market Leadership: Tenet Healthcare Earns 82 RS Rating appeared first on Investor's Business Daily.

Stocks Showing Rising Market Leadership: Tenet Healthcare Earns 82 RS Rating

FRISCO, Texas--(BUSINESS WIRE)--Conifer Health Solutions, LLC, a subsidiary of Tenet Healthcare Corporation (NYSE: THC), has announced the promotion of Mary Bacaj to president of its Conifer Value-Based Care, LLC business unit. Bacaj has served as a company vice president since 2015 and has led Value-Based Care since August 2019.

Conifer Health Names Mary Bacaj President of Value-Based Care

Riding high on divestitures and cost-reduction, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.

Why Should You Hold on to Tenet Healthcare (THC) Stock?

Tenet Healthcare (THC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.

Tenet Healthcare Offers Senior Unsecured Notes Worth $2.5B

Tenet (THC) reported earnings 30 days ago. What's next for the stock?

Why Is Tenet (THC) Up 6.9% Since Last Earnings Report?

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $2.5 billion in aggregate principal amount of senior notes due on October 1, 2028, which will bear interest at a rate of 6.125% per annum (the “notes”). Completion of the notes offering is expected to occur on September 16, 2020, and is subject to, among other things, standard closing and market conditions.

Tenet Announces Pricing of its $2.5 Billion Private Offering of Senior Notes

Tenet Healthcare Corp. THC, -2.18% said Tuesday it is planning to offer $2.5 billion of 8-year bonds, joining the many companies issuing debt during the pandemic at record levels.

Tenet Healthcare to offer $2.5 billion of 8-year bonds

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $2.5 billion in aggregate principal amount of newly issued senior notes maturing in 2028 (the “notes”). Completion of the offering is subject to, among other things, pricing and standard closing and market conditions.

Tenet Announces $2.5 Billion Private Offering of Senior Notes

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will participate in Baird’s 2020 Global Healthcare Conference on Wednesday, September 9, 2020. This year’s conference is being held via a virtual format.

Tenet to Participate in Baird’s 2020 Global Healthcare Conference

LOS ANGELES--(BUSINESS WIRE)--CIM Group, a community-focused real estate and infrastructure owner, operator, lender, and developer announced today that it has closed a $190 million bridge loan provided to Taconic Capital Advisors, the owner of International Plaza I & II, a 780,000-square-foot Class A office complex located in the Far North Dallas district. International Plaza I & II includes two office towers anchored by two long-term tenants, Tenant Healthcare (NYSE: THC) and Trinity I

CIM Group Provides $190 Million Mortgage Loan Secured by Class A Office Complex in Dallas

Tenet Healthcare's (THC) strategic measures and cost-controlling efforts are expected to support its margins, which in turn, might perk up its share price.

Tenet Healthcare Up 39% in a Year: Further Upside Left?

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced that Joseph Eazor has stepped down as CEO of Conifer Health Solutions, effective at the end of August. Mr. Eazor has made this decision for personal reasons unrelated to his working relationship at Conifer or Tenet.

Tenet Announces Executive Leadership Changes at Conifer

Tenet Healthcare Corp (THC) CEO Ronald Rittenmeyer on Q2 2020 Results - Earnings Call Transcript

Tenet Healthcare's (THC) Q2 earnings gain from operational performance, partly offset by lower revenues.

Tenet Healthcare (THC) Q2 Earnings Beat Estimates, Rise Y/Y

Tenet Healthcare shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 81.
The post Tenet Healthcare Hits 80-Plus Relative Strength Rating Benchmark appeared first on Investor's Business Daily.

Tenet Healthcare Hits 80-Plus Relative Strength Rating Benchmark

Tenet (THC) delivered earnings and revenue surprises of 227.27% and -4.76%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Tenet Healthcare (THC) Tops Q2 Earnings Estimates

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended June 30, 2020 (2Q20). Ronald A. Rittenmeyer, Executive Chairman and Chief Executive Officer, stated, “The second quarter was a challenge by any measure.

Tenet Reports Results for the Second Quarter Ended June 30, 2020 and Provides Update on Effects of COVID-19

Tenet Healthcare shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
The post Stocks Generating Improved Relative Strength: Tenet Healthcare appeared first on Investor's Business Daily.

News for Tenet Healthcare Stock (THC)